Nuformix plc 1RT.F Stock
Nuformix plc Price Chart
Nuformix plc 1RT.F Financial and Trading Overview
| Nuformix plc stock price | 0.0010 EUR |
| Previous Close | 0.0005 EUR |
| Open | 0.0005 EUR |
| Bid | 0.0005 EUR x N/A |
| Ask | 0.02 EUR x N/A |
| Day's Range | 0.0005 - 0.0005 EUR |
| 52 Week Range | 0.0005 - 0.0035 EUR |
| Volume | 3K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 2.13M EUR |
| Beta (5Y Monthly) | 0.438314 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1RT.F Valuation Measures
| Enterprise Value | 95.4K EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.083333336 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.132 |
Trading Information
Nuformix plc Stock Price History
| Beta (5Y Monthly) | 0.438314 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0035 EUR |
| 52 Week Low | 0.0005 EUR |
| 50-Day Moving Average | 0.0005 EUR |
| 200-Day Moving Average | 0.000675 EUR |
1RT.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 744.31M |
| Float | 596.73M |
| Short Ratio | N/A |
| % Held by Insiders | 18.45% |
| % Held by Institutions | 0.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -10.041% |
| Return on Equity (ttm) | -16.95% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -724404 EUR |
| Net Income Avi to Common (ttm) | -760136 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 259.26K EUR |
| Total Cash Per Share (mrq) | 0 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.418 |
| Book Value Per Share (mrq) | 0.006 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -433097 EUR |
| Levered Free Cash Flow (ttm) | -148774 EUR |
Profile of Nuformix plc
| Country | Germany |
| State | N/A |
| City | London |
| Address | 60 Gracechurch Street |
| ZIP | EC3V 0HR |
| Phone | 44 1223 627222 |
| Website | https://www.nuformix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Q&A For Nuformix plc Stock
What is a current 1RT.F stock price?
Nuformix plc 1RT.F stock price today per share is 0.0010 EUR.
How to purchase Nuformix plc stock?
You can buy 1RT.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuformix plc?
The stock symbol or ticker of Nuformix plc is 1RT.F.
Which industry does the Nuformix plc company belong to?
The Nuformix plc industry is Biotechnology.
How many shares does Nuformix plc have in circulation?
The max supply of Nuformix plc shares is 1.77B.
What is Nuformix plc Price to Earnings Ratio (PE Ratio)?
Nuformix plc PE Ratio is now.
What was Nuformix plc earnings per share over the trailing 12 months (TTM)?
Nuformix plc EPS is 0 EUR over the trailing 12 months.
Which sector does the Nuformix plc company belong to?
The Nuformix plc sector is Healthcare.